Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Savio Barreto; Shailesh V Shrikhande; Bhawna Sirohi

doi:10.1007/s13193-021-01361-1

Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Savio Barreto, Shailesh V Shrikhande, Bhawna Sirohi

College of Medicine and Public Health

Research output: Contribution to journal › Editorial

Abstract

In this perspective, we present our assessment of all of the known accumulated evidence on the role of neoadjuvant therapy in the management of borderline resectable pancreatic cancer highlighting the gaps in the data, the current regimens used and providing a brief insight into the way forward.

Original language	English
Number of pages	6
Journal	Indian Journal of Surgical Oncology
DOIs	https://doi.org/10.1007/s13193-021-01361-1
Publication status	E-pub ahead of print - 1 Jul 2021

Keywords

Neodajuvant Therapy
Pancreatic Cancer

Access to Document

10.1007/s13193-021-01361-1Licence: In Copyright

Cite this

@article{5d9c907a874d4605a2da1543a088cae2,

title = "Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer",

abstract = "In this perspective, we present our assessment of all of the known accumulated evidence on the role of neoadjuvant therapy in the management of borderline resectable pancreatic cancer highlighting the gaps in the data, the current regimens used and providing a brief insight into the way forward.",

keywords = "Neodajuvant Therapy, Pancreatic Cancer",

author = "Savio Barreto and Shrikhande, {Shailesh V} and Bhawna Sirohi",

year = "2021",

month = jul,

day = "1",

doi = "10.1007/s13193-021-01361-1",

language = "English",

journal = "Indian Journal of Surgical Oncology ",

issn = "0975-7651",

}

TY - JOUR

T1 - Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

AU - Barreto, Savio

AU - Shrikhande, Shailesh V

AU - Sirohi, Bhawna

PY - 2021/7/1

Y1 - 2021/7/1

N2 - In this perspective, we present our assessment of all of the known accumulated evidence on the role of neoadjuvant therapy in the management of borderline resectable pancreatic cancer highlighting the gaps in the data, the current regimens used and providing a brief insight into the way forward.

AB - In this perspective, we present our assessment of all of the known accumulated evidence on the role of neoadjuvant therapy in the management of borderline resectable pancreatic cancer highlighting the gaps in the data, the current regimens used and providing a brief insight into the way forward.

KW - Neodajuvant Therapy

KW - Pancreatic Cancer

U2 - 10.1007/s13193-021-01361-1

DO - 10.1007/s13193-021-01361-1

M3 - Editorial

JO - Indian Journal of Surgical Oncology

JF - Indian Journal of Surgical Oncology

SN - 0975-7651

ER -

Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Abstract

Keywords

Access to Document

Fingerprint

Cite this